India’s Bharat Biotech gets regulatory nod for shelf-life extension of its COVID-19 shot
A healthcare worker fills a syringe with a dose of Bharat Biotech’s COVID-19 vaccine called COVAXIN, during the coronavirus disease (COVID-19) vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan AbidiBENGALURU, Nov 3 (Reuters) – Bharat Biotech’s COVID-19 vaccine has been granted an extension of…Continue Reading









